publication date: May. 17, 2019

In Brief

Hollings Cancer Center receives NCI-designation renewal

Hollings Cancer Center of the Medical University of South Carolina received re-designation as an NCI Cancer Center.

The renewal is accompanied by $10.8 million in funding. Hollings has held this designation since 2009.

“This took an enormous effort from a large group of team members to be able to present and highlight the excellence at Hollings to the NCI leadership,” Hollings Cancer Center Director Gustavo Leone said in a statement. “We want to reach the medically underserved all through the state. While there is much work still to be done, this has been a major accomplishment over the past several years that has led to the appreciation of the NCI of what we are doing in our communities, and the value we bring.”

Key accomplishments since Hollings’ last renewal include:

Opening 392 cancer-related research studies and enrolled 3,522 adults and children in clinical trials (2014-2017)

Expanding mobile health van cancer screening and education to 27 counties throughout the state, serving more than 7,000 women in the past five years

Launching 42 clinical trials emanating from Hollings Cancer Center science (2013-2017)

Securing 138 peer-reviewed, extramural research project awards totaling over $40M (excluding training and career development grants), with more than $20M from the NCI in 2018.

Publishing 572 studies (2013-2017), including 93 in high impact journals.


Bold named physician-in-chief of UC Davis Comprehensive Cancer Center

Richard Bold, chief of the Division of Surgical Oncology, was named physician-in-chief of the UC Davis Comprehensive Cancer Center.

This new position gives Bold clinical oversight of outpatient and inpatient services as well as the center’s affiliated UC … Continue reading Hollings Cancer Center receives NCI-designation renewal

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.